Bronchiectasis (1 companies)

Companies with an active program in Bronchiectasis.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
INSM	Insmed	CardiovascularImmunology+3 Rare	2	Approved	$25.1B	15